About: Deubiquitylating Enzymes and DNA Damage Response Pathways

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Deubiquitylating Enzymes and DNA Damage Response Pathways Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Deubiquitylating Enzymes and DNA Damage Response Pathways
Creator	Jacq, Xavier Kemp, Mark Jackson, S Jackson, Stephen Jackson, Á Jacq, X Kemp, Á Martin, Niall Martin, Á
Source	PMC
abstract	Covalent post-translational modification of proteins by ubiquitin and ubiquitin-like factors has emerged as a general mechanism to regulate myriad intra-cellular processes. The addition and removal of ubiquitin or ubiquitin-like proteins from factors has recently been demonstrated as a key mechanism to modulate DNA damage response (DDR) pathways. It is thus, timely to evaluate the potential for ubiquitin pathway enzymes as DDR drug targets for therapeutic intervention. The synthetic lethal approach provides exciting opportunities for the development of targeted therapies to treat cancer: most tumours have lost critical DDR pathways, and thus rely more heavily on the remaining pathways, while normal tissues are still equipped with all DDR pathways. Here, we review key deubiquitylating enzymes (DUBs) involved in DDR pathways, and describe how targeting DUBs may lead to selective therapies to treat cancer patients.
has issue date	2013-05-28(xsd:dateTime)
bibo:doi	10.1007/s12013-013-9635-3
bibo:pmid	23712866
has license	no-cc
sha1sum (hex)	ee46c9064c2ef4916ba7d54c80236d3cb1781635
schema:url	https://doi.org/10.1007/s12013-013-9635-3
resource representing a document's title	Deubiquitylating Enzymes and DNA Damage Response Pathways
has PubMed Central identifier	PMC3756857
has PubMed identifier	23712866
schema:publication	Cell Biochem Biophys
resource representing a document's body	covid:ee46c9064c2ef4916ba7d54c80236d3cb1781635#body_text
is schema:about of	named entity 'development' named entity 'processes' named entity 'Here' named entity 'therapies' named entity 'DEVELOPMENT' named entity 'ENZYME' named entity 'ENZYMES' named entity 'CYCLOBUTANE' named entity 'SYNTHETIC LETHAL' named entity 'DEMONSTRATED' named entity 'SYNTHESIS' named entity 'UBIQUITIN' named entity 'ULTRA-VIOLET' named entity 'HYDROXYUREA' named entity 'DOUBLE' named entity 'DNA DAMAGE RESPONSE' named entity '2 O' named entity 'HOMOLOGOUS RECOMBINATION' named entity 'SELECTIVE' named entity 'GENERAL' named entity 'TIMELY' named entity 'NER' named entity 'TUMOURS' named entity 'MMC' named entity 'HAVE' named entity 'TARGETED' named entity '5FU' named entity 'INTRACELLULAR' named entity 'ADDITION' named entity 'PATIENTS' named entity 'FLUORO-URACIL' named entity 'MITOMYCIN C' named entity 'LIKE' covid:arg/ee46c9064c2ef4916ba7d54c80236d3cb1781635 named entity 'TARGETING' named entity 'POST-TRANSLATIONAL MODIFICATION' named entity 'INVOLVED' named entity 'REMAINING' named entity 'H 2' named entity 'DNA' named entity 'TLS' named entity 'RECENTLY' named entity 'LOST' named entity 'REMOVAL' named entity 'PYRIDINE' named entity 'THERAPIES' named entity 'IONISING RADIATION' named entity 'DRUG DISCOVERY' named entity 'HYDROGEN PEROXIDE' named entity 'PATHWAY' named entity 'POTENTIAL' named entity 'TREAT' named entity 'PATHWAYS' named entity 'DIMER' named entity 'NHEJ' named entity 'CPD' named entity 'LEAD' named entity 'NORMAL' named entity 'DESCRIBE' named entity 'DNA DAMAGE RESPONSE' named entity 'PATHWAYS' named entity 'ENZYMES' named entity 'ABBREVIATIONS' named entity 'DRUG TARGETS' named entity 'THERAPEUTIC INTERVENTION' named entity 'LESION' named entity 'NUCLEOTIDE EXCISION REPAIR' named entity 'BASE EXCISION REPAIR' named entity 'PROVIDES' named entity 'TISSUES' named entity 'DSB' named entity 'STRAND' named entity 'LIGHT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software